Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

    ... non-myeloablative HLA -identical sibling donor peripheral blood stem cell (PBSC) transplantation for the treatment of a high risk malignancy. ...

    Clinical Trial last updated 04/29/2016 - 1:48pm.

  2. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... this study the investigators are offering to treat the donor peripheral blood stem cells in the hope that it will make it less likely for the ...

    Clinical Trial last updated 04/27/2016 - 8:55am.

  3. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ... with standard non-transplant therapy, who will receive a peripheral blood stem cell transplant . A malignant disease includes the following: ...

    Clinical Trial last updated 05/03/2016 - 10:47am.

  4. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... of using a system called CliniMACS to remove Tcells from blood stem cells . Removing T-cells may help stop a side effect called ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  5. Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

    ... recover faster following a stem cell transplant . Blood stem cells are very young blood cells that grow in the body to ... hemoglobin ) Patients have a plan to receive a peripheral blood stem cell collection. Patients must have no change in ...

    Clinical Trial last updated 04/29/2016 - 1:11pm.

  6. Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant

    ... in patients with hematologic malignancies undergoing donor peripheral blood stem cell (PBSC) transplant. Giving chemotherapy and total-body ...

    Clinical Trial last updated 04/28/2016 - 12:07pm.

  7. Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT (RIC HSCT NMD)

    ... donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders ...

    Clinical Trial last updated 06/13/2016 - 2:18pm.

  8. Clone of Patients

    ...

    Page last updated 03/14/2016 - 6:05pm.

  9. Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... Patients undergo cluster of differentiation (CD)34+ peripheral blood stem cell transplant on day 0. GVHD PROPHYLAXIS: Patients receive ...

    Clinical Trial last updated 04/27/2016 - 1:37pm.

  10. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... adolescents and young adults receiving an allogeneic peripheral blood Status:  Recruiting ...

    Clinical Trial last updated 06/13/2016 - 2:06pm.